Oxidative stress-induced DNA damage and cell cycle regulation in B65 dopaminergic cell line

Free Radical Research

Volumn 43, Issue 10, 2009, Pages 985-994

  Pizarro, Javier G ^a   Folch, Jaume ^b   Vazquez De La Torre, Aurelio ^a   Verdaguer, Ester ^a   Junyent, Felix ^a   Jordán, Joaquín ^c   Pallás, Mercé ^a   Camins, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^c Universidad de Castilla La Mancha   (Spain)

Author keywords

Apoptosis; ATM; Cell cycle; KU 55933; Retinoblastoma protein

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; HYDROGEN PEROXIDE; PROTEIN P53; RETINOBLASTOMA PROTEIN; SERINE; SIRTUIN 1; STAT1 PROTEIN; TROLOX C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DOPAMINERGIC NERVE CELL; DOUBLE STRANDED DNA BREAK; DRUG MECHANISM; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HYDROGEN PEROXIDE; NEUROBLASTOMA; NEURONS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RATS; REACTIVE OXYGEN SPECIES; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

RATTUS;

EID: 70450253285     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760903159188     Document Type: Article

References (49)

1. Toyokuni S, Akatsuka S. Pathological investigation of oxidative stress in the post-genomic era. Pathol Int 2007;57:461-473.
2. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1-11.
3. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009;46:531-542.
4. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
5. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signalling. Am J Physiol Lung Cell Mol Physiol 2000;279:L1005-L1028.
6. Lee Y, McKinnon PJ. ATM dependent apoptosis in the nervous system. Apoptosis 2000;5:523-529.
7. O'Connor PM. Mammalian G1 and G2 phase checkpoints. Cancer Surv 1997;29:151-182.
8. Khanna KK, Lavin MF, Jackson SP, Mulhern TD. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 2001;8:1052-1065.
9. Kurz EU, Douglas P, Lees-Miller SP. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair 2004;3:889-900.
10. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-1753.
11. Rotman G, Shiloh Y Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays 1997;19:911-917.
12. Pallas M, Casadesus G, Smith MA, Coto-Montes A, Pelegri C, Vilaplana J, Camins A. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 2009;6:70-81.
13. Pallas M, Verdaguer E, Tajes M, Gutierrez-Cuesta J, Camins A. Modulation of sirtuins: new targets for antiageing. Recent Pat CNS Drug Discov 2008;3:61-69.
14. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-323.
15. Liu B, Chen Y, St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 2008;44:1529-1535.
16. Zhang P, Dilley C, Mattson MP. DNA damage responses in neural cells: focus on the telomere. Neuroscience 2007;145:1439-1448.
17. Culmsee C, Mattson MP. p53 in neuronal apoptosis. Biochem Biophys Res Commun 2005;331:761-777.
18. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998;280:1089-1091.
19. Otsuka Y, Tanaka T, Uchida D, Noguchi Y, Saeki N, Saito Y, Tatsuno I. Roles of cyclin-dependent kinase 4 and p53 in neuronal cell death induced by doxorubicin on cerebellar granule neurons in mouse. Neurosci Lett 2004;365:180-185.
20. Nair VD. Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. Apoptosis 2006;11:955-966.
21. Gilman CP, Chan SL, Guo Z, Zhu X, Greig N, Mattson MP. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromol Med 2003;3:159-172.
22. Wyttenbach A, Tolkovsky AM. The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons. J Neuro-chem 2006;96:1213-1226.
23. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, Slack RS, Park DS. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J Neurosci 2004;24:2963-2973.
24. Keramaris E, Hirao A, Slack RS, Mak TW, Park DS. Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage. J Biol Chem 2003;278:37782-37789.
25. Gomez-Lazaro M, Galindo MF, Fernandez-Gomez FJ, Prehn JH, Jordan J. Activation of p53 and the pro-apoptotic p53 target gene PUMA during depolarization-induced apoptosis of chromaffin cells. Exp Neurol 2005;196:96-103.
26. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 2004;64:9152-9159.
27. Kuo LJ, Yang LX. Gamma-H2AX*a novel biomarker for DNA double-strand breaks. In Vivo 2008;22:305-309.
28. Crescenzi E, Palumbo G, de Boer J, Brady HJ. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy. Clin Cancer Res 2008;14:1877-1887.
29. Myung NH, Zhu X, Kruman II, Castellani RJ, Petersen RB, Siedlak SL, Perry G, Smith MA, Lee HG. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age 2008;30:209-215.
30. Kim HS, Lee MS. STAT1 as a key modulator of cell death. Cell Signal 2007;19:454-465
31. Klampfer L. Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemother-apeutic drugs. Curr Cancer Drug Targets 2006;6:107-121.
32. Stephanou A. Role of STAT-1 and STAT-3 in ischaemia/ reperfusion injury. J Cell Mol Med 2004;8:519-525.
33. Townsend PA, Cragg MS, Davidson SM, McCormick J, Barry S, Lawrence KM, Knight RA, Hubank M, Chen PL, Latchman DS, Stephanou A. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J Cell Sci 2005;118:1629-1639.
34. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005;9:59-71.
35. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999;274:22699-22704.
36. Menon SG, Goswami PC. A redox cycle within the cell cycle: ring in the old with the new. Oncogene 2007;26:1101-1109.
37. Baus F, Gire V, Fisher D, Piette J, Dulic V. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J 2003;22:3992-4002
38. Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 2006;25:6731-6748.
39. Inoue Y, Kitagawa M, Taya Y Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J 2007;26:2083-2093.
40. Hamdane M, Buee L. The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle. Biotechnol J 2007;2:967-977.
41. Camins A, Verdaguer E, Folch J, Canudas AM, Pallas M. The role of CDK5/P25 formation/inhibition in neurodegenera-tion. Drug News Perspect 2006;19:453-460
42. Thakur A, Siedlak SL, James SL, Bonda DJ, Rao A, Webber KM, Camins A, Pallas M, Casadesus G, Lee HG, Bowser R, Raina AK, Perry G, Smith MA, Zhu X. Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. Int J Clin Exp Pathol 2008;1:134-146.
43. Zhu X, Lee HG, Perry G, Smith MA. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 2007;1772:494-502.
44. Zhu X, Raina AK, Perry G, Smith MA. Alzheimer?s disease: the two-hypotheses. Lancet Neurol 2004;3:219-226.
45. Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, Roberts LJ 2nd, Wynshaw-Boris A, Levine RL. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci USA 1999;96: 9915-9919.
46. Lavin MF, Shiloh Y. Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. Curr Opin Immunol 1996;8:459-464
47. Tian B, Yang Q, Mao Z. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 2009;11:211-218.
48. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006;12:440-450.
49. Seoane M, Iglesias P, Gonzalez T, Dominguez F, Fraga M, Aliste C, Forteza J, Costoya JA. Retinoblastoma loss modulates DNA damage response favouring tumor progression. PLoS ONE 2008;3:e3632.